Pleuritis is a red flag for adult-onset Still's disease which may require biologic therapies

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 807-

  Quartuccio, L ^a   Salvin, S ^a   Zuliani, F ^a   Mansutti, E ^a   De Vita, S ^a  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; AZATHIOPRINE; CERTOLIZUMAB PEGOL; CHLOROQUINE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TOCILIZUMAB;

ADOLESCENT; ADULT; ADULT ONSET STILL DISEASE; AGED; BIOLOGICAL THERAPY; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DIVERTICULITIS; DRUG EFFICACY; FEMALE; HUMAN; LETTER; LOW DRUG DOSE; MALE; PLEURISY; PRIORITY JOURNAL; PROGNOSIS; RASH; THROMBOCYTOPENIA; TREATMENT RESPONSE; URTICARIA;

ADOLESCENT; ADULT; AGED; BIOLOGICAL AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PLEURISY; STILL'S DISEASE, ADULT-ONSET; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870278554     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. BAYWATERS EG: Still's disease in the adult. Ann Rheum Dis 1971;30:121-33.
2. FAUTREL B: Adult-onset Still disease. Best Pract Res Clin Rheum 2008;22:773-92.
3. PRIORI R, COLAFRANCESCO S, PICARELLI G, DI FRANCO M, VALESINI G: Adult-onset Still's disease: not always so good. Clin Exp Rheumatol 2012;30:142.
4. EFTHIMIOU P, PAIK PK, BIELORY L: Diagnosis and management of adult-onset Still's disease. Ann Rheum Dis 2006;65:564-72.
5. YAMAGUCHI M, OHTA A, TSUNEMATSU T, KASUKAWA R, MIZUSHIMA Y, KASHIWAGI H: Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
6. FAUTREL B, SIBILIA J, MARIETTE X, COMBE B: Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases. Ann Rheum Dis 2005;64:262-6.
7. PUÉCHAL X, DEBANDT M, BERTHELOT JM et al.: Tocilizumab in refractory adult Still's disease. Arthritis Care Res (Hoboken). 2011;63:155-9.
8. EFTHIMIOU P, FLAVELL RA, FURLAN A et al.: Autoinflammatory syndromes and infections: pathogenetic and clinical implications. Clin Exp Rheumatol 2008;26(Suppl. 48):S53-61.
9. ZENG T, ZOU YQ, WU MF, YANG CD: Clinical features and prognosis of adult-onset Still's disease: 61 cases from China. J Rheumatol 2009;36:1026-31.
10. ZOU YQ, LU U, LI SJ et al.: The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease. Clin Biochem 2008;41:519-24.